AN2 Therapeutics Inc. has engaged in share transactions with Coastlands Capital Partners LP. On June 17, 2025, Coastlands Capital exchanged 2,500,000 shares of the company's common stock for a pre-funded warrant to acquire an equivalent number of shares. Similarly, on June 19, 2025, 300,000 shares of common stock were exchanged for a pre-funded warrant to acquire 300,000 shares. The pre-funded warrants have an exercise price of $0.00001 per share and are exercisable at any time until fully exercised.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.